AveryME, MeadJ.Surface properties in relation to atelectasis and hyaline membrane disease. AJDC1959;97:517–523.
2.
RobillardE, AlarieY, Dagenais-PeruseP, . Microaerosol administration of synthetic β-y-dipalmitoyl-d-lecithin in the respiratory distress syndrome: A preliminary report. Can Med Assoc J1964;90:55–57.
RobertsonB, EnhorningG.The alveolar lining of the premature newborn rabbit after pharyngeal deposition of surfactant. Lab Invest1974;31:54–59.
5.
EnhorningG, RobertsonB, MilneE, WagnerR.Radiologic evaluation of the premature newborn rabbit after pharyngeal depositon of surfactant. Am J Obstet Gynecol1975;121:475–480.
6.
LachmannB, GrossmannG, NilssonR, RobertsonB.Effect of supplementary surfactant on in vivo lung mechanics in the premature rabbit neonate. Eur J Pediatr1981;136:173–179.
7.
EnhorningG, GrossmannG, RobertsonB.Tracheal deposi-tion of surfactant before the first breath. Am Rev Respir Dis1973;107:921–927.
8.
EnhorningG, HillD, SherwoodG, . Improved ventilation of prematurely delivered primates following tracheal deposition of surfactant. Am J Obstet Gynecol1978;132:529–536.
9.
AdamsFH, TowersB, OsherAB, . Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr Res1978;12:841–848.
KingRJ. Isolation and chemical composition of pulmonary surfactant. In: RobertsonB, Van GoldeLMG, BatenburgJJ, editors. Pulmonary surfactant. Amsterdam: Elsevier, 1984:1–15.
12.
GluckL, KulovichMV, BorerRC, KeidelWN. The interpretation and significance of the lecithin/sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol1974;120:142–154.
13.
FujiwaraT.Surfactant replacement in neonatal RDS. In: RobertsonB, Van GoldeLMG, BatenburgJJ, editors. Pulmonary surfactant. Amsterdam: Elsevier, 1984:479–503.
14.
NotterRH, EganEA, KwongMS, . Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique, and gestational age. Pediatr Res1985;19:569–577.
15.
MagoonMW, WrightJR, BaritussioA, . Subfrac-tionation of lung surfactant: Implications for metabolism and surface activity. Biochim Biophys Acta1983;750:18–31.
16.
WrightJR, BensonBJ, GoerkeWJ, . Protein composition of rabbit alveolar surfactant subfractions. Biochim Biophys Acta1984;791:320–332.
17.
BermelMS, McBrideJJ, NotterRA. Lavaged excised rat lungs as a model of surfactant deficiency. Lung1984;162:99–113.
18.
JacobsHC, BerryD, DuaneG, . Normalization of arterial blood gases following treatment of surfactant-deficient lambs with Tween 20. Am Rev Respir Dis1985;132:1313–1381.
19.
MarksLB, NotterRH, OberdorsterG, McBrideJT. Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity. Pediatr Res1983;17:742–747.
20.
IkegamiM, AdamsFH, TowersB, OsherAB. The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs. Pediatr Res1980;14:1082–1085.
21.
JobeA, IkegamiM, JacobsH, JonesS.Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant. J Clin Invest1984;73:848–856.
22.
HallmanM, MerrittTA, JarvenpaaA-L, . Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial. J Pediatr1985;106:963–969.
23.
JobeA, IkegamiM.The prematurely delivered lamb as a model for studies of neonatal adaptation. In: NathanielszPW, editor. Animal models in fetal medicine. Ithaca NY: Perinatology Press, 1984:1–30.
24.
HallmanM, MerrittTA, SchneiderH, . Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome. Pediatrics1983;71:473–482.
25.
EnhorningG, ShennanA, PossmayerF, . Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics1985;76:145–153.
26.
KwongMS, EganEA, NotterRH, ShapiroDL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics1985;76:585–592.
27.
ShapiroDL, NotterRH, MorinFCIII, . Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics1985;76:593–599.
28.
MorleyCJ, MillerN, BanghamAD. Dry artificial lung surfactant and its effect on very premature babies. Lancet1981;1:64–68.
29.
MilnerA, VyasH, HopkinI.Effect of exogenous surfactant on total respiratory system compliance. Arch Dis Child1984;59:369–371.
30.
WilkinsonAR, JefferyJA, JenkinsPA. Controlled trials of dry surfactant in pre-term infants (abstract). Arch Dis Child1982;57:802A.
31.
DurandD, ClymanRI, HeymannMA, . Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. J Pediatr1985;107:775–780.
32.
EganEA, NotterRH, KwongMS, ShapiroDL. Natural and artificial lung surfactant replacement therapy in premature lambs. J Appl Physiol1983;55:875–883.
33.
IkegamiM, AgataY, ElKadyT, . A comparison of four surfactants' in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics, in press.
34.
JobeA, IkegamiM, GlatzT, . Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest1981;67:370–375.
35.
JacobsH, JobeA, IkegamiM, . Premature lambs rescued from respiratory failure with natural surfactant: Clinical and biophysical correlates. Pediatr Res1982;16:424–429.
36.
JobeA, JacobsH, IkegamiM, BerryD.Lung protein leaks in ventilated lambs: Effect of gestational age. J Appl Physiol1985;58:1246–1251.
37.
JeffriesAL, CoatesG, O'BrodovichH.Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med1984;311:1075–1080.
38.
JobeA, IkegamiM, JacobsH, . Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol1983;55:169–176.
39.
IkegamiM, JobeA, JacobsH, LamR.A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol1984;57:1134–1142.
HallidayHL, ReidMM, MebanC, . Controlled trial of artificial surfactant to prevent respiratory distress syndrome. Lancet1984;1:476–478.
42.
ClymanRI, JobeA, HeymannM, . Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr1982;100:101–107.
43.
OguchiK, IkegamiM, JacobsH, JobeA.Clearance of large amounts of natural surfactant and DPPC from lungs of 3-day-old rabbits following tracheal injection. Exp Lung Res1985;9:221–235.
44.
JobeA, IkegamiM, GlatzT, . Saturated phospha-tidylcholine secretion and the effect of natural surfactant on premature and term lambs ventilated for 2 days. Exp Lung Res1983;4:259–267.
45.
GlatzT, IkegamiM, JobeA.Metabolism of exogenously administered natural surfactant in the newborn lamb. Pediatr Res1982;16:711–715.
